Skip to main content
Erschienen in: Clinical & Experimental Metastasis 2/2024

28.02.2024 | Research

Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics

verfasst von: Shengcai Wei, Xinyi Gou, Yinli Zhang, Jingjing Cui, Xiaoming Liu, Nan Hong, Weiqi Sheng, Jin Cheng, Yi Wang

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Chemotherapy alters the prognostic biomarker histopathological growth pattern (HGP) phenotype in colorectal liver metastases (CRLMs) patients. We aimed to develop a CT-based radiomics model to predict the transformation of the HGP phenotype after chemotherapy. This study included 181 patients with 298 CRLMs who underwent preoperative contrast-enhanced CT followed by partial hepatectomy between January 2007 and July 2022 at two institutions. HGPs were categorized as pure desmoplastic HGP (pdHGP) or non-pdHGP. The samples were allocated to training, internal validation, and external validation cohorts comprising 153, 65, and 29 CRLMs, respectively. Radiomics analysis was performed on pre-enhanced, arterial phase, portal venous phase (PVP), and fused images. The model was used to predict prechemotherapy HGPs in 112 CRLMs, and HGP transformation was analysed by comparing these findings with postchemotherapy HGPs determined pathologically. The prevalence of pdHGP was 19.8% (23/116) and 45.8% (70/153) in chemonaïve and postchemotherapy patients, respectively (P < 0.001). The PVP radiomics signature showed good performance in distinguishing pdHGP from non-pdHGPs (AUCs of 0.906, 0.877, and 0.805 in the training, internal validation, and external validation cohorts, respectively). The prevalence of prechemotherapy pdHGP predicted by the radiomics model was 33.0% (37/112), and the prevalence of postchemotherapy pdHGP according to the pathological analysis was 47.3% (53/112; P = 0.029). The transformation of HGP was bidirectional, with 15.2% (17/112) of CRLMs transforming from prechemotherapy pdHGP to postchemotherapy non-pdHGP and 30.4% (34/112) transforming from prechemotherapy non-pdHGP to postchemotherapy pdHGP (P = 0.005). CT-based radiomics method can be used to effectively predict the HGP transformation in chemotherapy-treated CRLM patients, thereby providing a basis for treatment decisions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Galjart B et al (2019) Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis 22(2):355–368CrossRefPubMedPubMedCentral Galjart B et al (2019) Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis 22(2):355–368CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Buisman FE et al (2022) Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. Eur J Cancer 168:25–33CrossRefPubMedPubMedCentral Buisman FE et al (2022) Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. Eur J Cancer 168:25–33CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Falcao D et al (2018) Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - pushing growth as an independent risk factor for decreased survival. Eur J Surg Oncol 44(8):1212–1219CrossRefPubMed Falcao D et al (2018) Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - pushing growth as an independent risk factor for decreased survival. Eur J Surg Oncol 44(8):1212–1219CrossRefPubMed
4.
Zurück zum Zitat Fonseca GM et al (2018) Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology 72(3):377–390CrossRefPubMed Fonseca GM et al (2018) Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology 72(3):377–390CrossRefPubMed
5.
Zurück zum Zitat van Dam PJ et al (2018) Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. Semin Cancer Biol 52 Pt 2): 86–93 van Dam PJ et al (2018) Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. Semin Cancer Biol 52 Pt 2): 86–93
6.
Zurück zum Zitat van Dam PJ et al (2017) International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer 117(10):1427–1441CrossRefPubMedPubMedCentral van Dam PJ et al (2017) International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer 117(10):1427–1441CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hoppener DJ et al (2022) The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases. BMC Cancer 22(1):911CrossRefPubMedPubMedCentral Hoppener DJ et al (2022) The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases. BMC Cancer 22(1):911CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Fleischer JR et al (2023) Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol Cancer 22(1):17CrossRefPubMedPubMedCentral Fleischer JR et al (2023) Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol Cancer 22(1):17CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Latacz E et al (2022) Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br J Cancer 127(6):988–1013CrossRefPubMedPubMedCentral Latacz E et al (2022) Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br J Cancer 127(6):988–1013CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Vigano L et al (2014) Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol 21(4):1276–1286CrossRefPubMed Vigano L et al (2014) Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol 21(4):1276–1286CrossRefPubMed
12.
Zurück zum Zitat Buisman FE et al (2020) Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. Clin Exp Metastasis 37(5):593–605CrossRefPubMedPubMedCentral Buisman FE et al (2020) Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. Clin Exp Metastasis 37(5):593–605CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Eefsen RL et al (2016) Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab. Int J Cancer 138(7):1777–1784CrossRefPubMed Eefsen RL et al (2016) Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab. Int J Cancer 138(7):1777–1784CrossRefPubMed
14.
Zurück zum Zitat Messaoudi N et al (2022) Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns. Br J Cancer 126(9):1329–1338CrossRefPubMedPubMedCentral Messaoudi N et al (2022) Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns. Br J Cancer 126(9):1329–1338CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Nierop PM et al (2022) Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases. J Pathol Clin Res 8(1):48–64CrossRefPubMed Nierop PM et al (2022) Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases. J Pathol Clin Res 8(1):48–64CrossRefPubMed
16.
17.
Zurück zum Zitat Dalal V et al (2020) Radiomics in stratification of pancreatic cystic lesions: machine learning in action. Cancer Lett 469:228–237CrossRefPubMed Dalal V et al (2020) Radiomics in stratification of pancreatic cystic lesions: machine learning in action. Cancer Lett 469:228–237CrossRefPubMed
18.
Zurück zum Zitat Sun R et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19(9):1180–1191CrossRefPubMed Sun R et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19(9):1180–1191CrossRefPubMed
19.
Zurück zum Zitat Ganeshan B et al (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10(1):137–143CrossRefPubMedPubMedCentral Ganeshan B et al (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10(1):137–143CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Cheng J et al (2019) Prediction of histopathologic growth patterns of Colorectal Liver metastases with a noninvasive imaging method. Ann Surg Oncol 26(13):4587–4598CrossRefPubMed Cheng J et al (2019) Prediction of histopathologic growth patterns of Colorectal Liver metastases with a noninvasive imaging method. Ann Surg Oncol 26(13):4587–4598CrossRefPubMed
21.
Zurück zum Zitat Latacz E et al (2021) Can medical imaging identify the histopathological growth patterns of liver metastases? Semin Cancer Biol 71:33–41CrossRefPubMed Latacz E et al (2021) Can medical imaging identify the histopathological growth patterns of liver metastases? Semin Cancer Biol 71:33–41CrossRefPubMed
22.
Zurück zum Zitat Starmans MPA et al (2021) Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clin Exp Metastasis 38(5):483–494CrossRefPubMedPubMedCentral Starmans MPA et al (2021) Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clin Exp Metastasis 38(5):483–494CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Taghavi M et al (2021) Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY) 46(1):249–256CrossRefPubMed Taghavi M et al (2021) Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY) 46(1):249–256CrossRefPubMed
24.
Zurück zum Zitat Wei S et al (2021) Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy. Eur J Radiol 142:109863CrossRefPubMed Wei S et al (2021) Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy. Eur J Radiol 142:109863CrossRefPubMed
25.
Zurück zum Zitat Cheng J et al (2020) Enhanced Rim on MDCT of Colorectal Liver metastases: Assessment of ability to Predict Progression-Free Survival and Response to Bevacizumab-based chemotherapy. Am J Roentgenol 215(6):1377–1383CrossRef Cheng J et al (2020) Enhanced Rim on MDCT of Colorectal Liver metastases: Assessment of ability to Predict Progression-Free Survival and Response to Bevacizumab-based chemotherapy. Am J Roentgenol 215(6):1377–1383CrossRef
28.
Zurück zum Zitat Hoppener DJ et al (2021) Histopathological growth patterns and Survival after Resection of Colorectal Liver Metastasis: an external validation study. JNCI Cancer Spectr 5:3CrossRef Hoppener DJ et al (2021) Histopathological growth patterns and Survival after Resection of Colorectal Liver Metastasis: an external validation study. JNCI Cancer Spectr 5:3CrossRef
29.
Zurück zum Zitat Han Y et al (2020) Identification of predominant histopathological growth patterns of colorectal liver metastasis by Multi-habitat and Multi-sequence Based Radiomics Analysis. Front Oncol 10:1363CrossRefPubMedPubMedCentral Han Y et al (2020) Identification of predominant histopathological growth patterns of colorectal liver metastasis by Multi-habitat and Multi-sequence Based Radiomics Analysis. Front Oncol 10:1363CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Zaharia C et al (2022) Histopathological growth pattern in Colorectal Liver Metastasis and the Tumor Immune Microenvironment. Cancers (Basel) 15:1CrossRef Zaharia C et al (2022) Histopathological growth pattern in Colorectal Liver Metastasis and the Tumor Immune Microenvironment. Cancers (Basel) 15:1CrossRef
31.
Zurück zum Zitat Chun YS et al (2009) Association of Computed Tomography Morphologic Criteria with Pathologic Response and SurvivalinPatientsTreatedWithBevacizumab for Colorectal Liver metastases. JAMA 02(302):21 Chun YS et al (2009) Association of Computed Tomography Morphologic Criteria with Pathologic Response and SurvivalinPatientsTreatedWithBevacizumab for Colorectal Liver metastases. JAMA 02(302):21
32.
Zurück zum Zitat Lunevicius R et al (2001) Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 127(3):193–199CrossRefPubMed Lunevicius R et al (2001) Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 127(3):193–199CrossRefPubMed
33.
Zurück zum Zitat Mentha G et al (2009) Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 96(1):95–103CrossRefPubMed Mentha G et al (2009) Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 96(1):95–103CrossRefPubMed
34.
Zurück zum Zitat Lazaris A et al (2018) Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies. J Pathol Clin Res 4(3):184–192CrossRefPubMedPubMedCentral Lazaris A et al (2018) Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies. J Pathol Clin Res 4(3):184–192CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Van den Eynde M et al (2018) The link between the Multiverse of Immune Microenvironments in metastases and the survival of Colorectal Cancer patients. Cancer Cell 34(6):1012–1026e3CrossRefPubMed Van den Eynde M et al (2018) The link between the Multiverse of Immune Microenvironments in metastases and the survival of Colorectal Cancer patients. Cancer Cell 34(6):1012–1026e3CrossRefPubMed
Metadaten
Titel
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics
verfasst von
Shengcai Wei
Xinyi Gou
Yinli Zhang
Jingjing Cui
Xiaoming Liu
Nan Hong
Weiqi Sheng
Jin Cheng
Yi Wang
Publikationsdatum
28.02.2024
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 2/2024
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-024-10275-5

Weitere Artikel der Ausgabe 2/2024

Clinical & Experimental Metastasis 2/2024 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.